Clinical Trial Update: A Phase IV Study of Recombinant Human Gamma Interferon in Patients With Chronic Granulomatous Diseases of Childhood [Phase 4]

View source ↗

Summary

A Phase IV study evaluating recombinant human gamma interferon in children with Chronic Granulomatous Disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatous Disease

Drugs mentioned

• Interferon-gamma 1b (interferon gamma-1b)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Chronic Granulomatous Disease | Phase 4 | Status: COMPLETED